Brief: Tetra Bio-Pharma Confirms Meetings With FDA
July 26 (Reuters) - Tetra Bio Pharma Inc TBP.V :
* TETRA BIO-PHARMA CONFIRMS MEETINGS WITH FDA
* TETRA BIO PHARMA INC - GOT 2 MEETING GRANTED LETTERS FROM
FDA
FOR TYPE B & C MEETS
* TETRA BIO- MEETS TO DISCUSS REQUIREMENTS FOR GETTING
MARKETING
APPROVAL UNDER 505(B)(2) REGULATORY PATHWAY FOR DRONABINOL
ADVERSA MUCOADHESIVE PRODUCT
Source text for Eikon: ID:nGNX6W9fg7
Further company coverage: TBP.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tetra Bio Pharma
See all newsBrief: Tetra Bio Receives A Second Clarifax From Health Canada Regarding Reduvo Risk Management Plan
Brief: Tetra Bio-Pharma Announces Results Of Artificial Intelligence Study Of ARDS-003 Combined With Favipiravir
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra And Prepaire Jointly Apply To Barda For Funding